Variant report

Variant	esv3353761
Chromosome Location	chr1:215255604-215257627
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:127)
CpG islands
(count:732)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:127 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr1:215256809-215257090	IMR90	lung:	n/a	n/a
2	CHD2	chr1:215255939-215256139	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTBP2	chr1:215255151-215256317	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr1:215255980-215256130	HAc	cerebellar:	n/a	n/a
5	CTCF	chr1:215255960-215256110	AG04450	lung:	n/a	n/a
6	CTCF	chr1:215256016-215256037	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr1:215255980-215256130	HMEC	breast:	n/a	n/a
8	CTCF	chr1:215255660-215255810	AG04449	skin:	n/a	n/a
9	CTCF	chr1:215256000-215256150	HCPEpiC	choroid plexus:	n/a	n/a
10	CTCF	chr1:215256060-215256210	WERI-Rb-1	eye:	n/a	n/a
11	CTCF	chr1:215255920-215256070	AG09309	skin:	n/a	n/a
12	CTCF	chr1:215255960-215256110	HPAF	blood vessel:	n/a	n/a
13	CTCF	chr1:215255900-215256050	HFF-Myc	foreskin:	n/a	n/a
14	CTCF	chr1:215256000-215256150	AG10803	skin:	n/a	n/a
15	CTCF	chr1:215255960-215256110	HCFaa	heart:	n/a	n/a
16	CTCF	chr1:215255920-215256070	NHDF-neo	bronchial:	n/a	n/a
17	CTCF	chr1:215255940-215256090	AG09309	skin:	n/a	n/a
18	CTCF	chr1:215255980-215256130	HMF	breast:	n/a	n/a
19	CTCF	chr1:215256020-215256170	HA-sp	spinal cord:	n/a	n/a
20	CTCF	chr1:215255960-215256110	AG04449	skin:	n/a	n/a
21	CTCF	chr1:215255940-215256090	HPAF	blood vessel:	n/a	n/a
22	CTCF	chr1:215255920-215256070	HBMEC	blood vessel:	n/a	n/a
23	CTCF	chr1:215256003-215256068	MCF-7	breast:	n/a	n/a
24	CTCF	chr1:215255880-215256030	HUVEC	blood vessel:	n/a	n/a
25	CTCF	chr1:215256060-215256210	AoAF	blood vessel:	n/a	n/a
26	CTCF	chr1:215255980-215256130	BJ	skin:	n/a	n/a
27	CTCF	chr1:215256001-215256144	MCF-7	breast:	n/a	n/a
28	CTCF	chr1:215256000-215256150	NHEK	skin:	n/a	n/a
29	CTCF	chr1:215256020-215256170	HEK293	kidney:	n/a	n/a
30	CTCF	chr1:215255880-215256030	HRE	kidney:	n/a	n/a
31	CTCF	chr1:215256145-215256228	MCF-7	breast:	n/a	n/a
32	CTCF	chr1:215255920-215256070	AG04449	skin:	n/a	n/a
33	CTCF	chr1:215255960-215256110	AG09319	gingival:	n/a	n/a
34	CTCF	chr1:215255980-215256130	AG04450	lung:	n/a	n/a
35	E2F4	chr1:215256712-215256745	MCF10A-Er-Src	breast:	n/a	n/a
36	E2F6	chr1:215255790-215256330	H1-hESC	embryonic stem cell:	n/a	n/a
37	E2F6	chr1:215256486-215257252	H1-hESC	embryonic stem cell:	n/a	chr1:215256543-215256552
38	E2F6	chr1:215256539-215257213	H1-hESC	embryonic stem cell:	n/a	chr1:215256543-215256552
39	EGR1	chr1:215256151-215256332	K562	blood:	n/a	chr1:215256283-215256297
40	EGR1	chr1:215255908-215256357	H1-hESC	embryonic stem cell:	n/a	chr1:215256283-215256297
41	EGR1	chr1:215256180-215256321	GM12878	blood:	n/a	chr1:215256283-215256297
42	FOXA1	chr1:215256894-215257341	T-47D	breast:	n/a	n/a
43	GATA3	chr1:215256749-215257422	T-47D	breast:	n/a	chr1:215256927-215256935
44	GATA3	chr1:215256463-215257448	T-47D	breast:	n/a	chr1:215256927-215256935
45	JUND	chr1:215255649-215255674	H1-hESC	embryonic stem cell:	n/a	n/a
46	KAP1	chr1:215256992-215257175	HEK293	kidney:	n/a	n/a
47	MAX	chr1:215256665-215257137	H1-hESC	embryonic stem cell:	n/a	n/a
48	MAX	chr1:215255837-215256395	H1-hESC	embryonic stem cell:	n/a	n/a
49	MAX	chr1:215256615-215257323	SK-N-SH	brain:	n/a	n/a
50	MAX	chr1:215255863-215256470	H1-hESC	embryonic stem cell:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:215257222-215257272	Hela-S3	cervix:	n/a
2	chr1:215257222-215257272	HCT-116	colon:	n/a
3	chr1:215256451-215256501	MCF-7	breast:	n/a
4	chr1:215256262-215256312	SK-N-SH_RA	brain:	n/a
5	chr1:215256635-215256685	GM12878	blood:	n/a
6	chr1:215257222-215257272	AG10803	skin:	n/a
7	chr1:215256254-215256304	SKMC	muscle:	n/a
8	chr1:215256870-215256920	AoSMC	blood vessel:	n/a
9	chr1:215256745-215256795	ovcar-3	ovarian:	n/a
10	chr1:215256635-215256685	SK-N-SH_RA	brain:	n/a
11	chr1:215256887-215256937	HL-60	blood:	n/a
12	chr1:215255716-215255766	SK-N-MC	brain:	n/a
13	chr1:215256262-215256312	HUVEC	blood vessel:	n/a
14	chr1:215257222-215257272	RPTEC	kidney:	n/a
15	chr1:215256978-215257028	H1-hESC	embryonic stem cell:	embryo
16	chr1:215256262-215256312	PrEC	prostate:	n/a
17	chr1:215256887-215256937	HEEpiC	esophagus:	n/a
18	chr1:215256451-215256501	HEEpiC	esophagus:	n/a
19	chr1:215257222-215257272	SK-N-SH_RA	brain:	n/a
20	chr1:215256745-215256795	T-47D	breast:	n/a
21	chr1:215257222-215257272	HepG2	liver:	n/a
22	chr1:215257222-215257272	HCF	heart:	n/a
23	chr1:215256451-215256501	SK-N-MC	brain:	n/a
24	chr1:215256745-215256795	CMK	blood:	n/a
25	chr1:215256978-215257028	NH-A	brain:	n/a
26	chr1:215256262-215256312	AG04449	skin:	fetal
27	chr1:215255572-215255622	AG04450	lung:	fetal
28	chr1:215256451-215256501	NB4	blood:	n/a
29	chr1:215256254-215256304	T-47D	breast:	n/a
30	chr1:215256448-215256498	NB4	blood:	n/a
31	chr1:215256451-215256501	SK-N-SH	brain:	n/a
32	chr1:215256635-215256685	NT2-D1	testis:	n/a
33	chr1:215256635-215256685	ovcar-3	ovarian:	n/a
34	chr1:215256451-215256501	AG09309	skin:	n/a
35	chr1:215256635-215256685	CMK	blood:	n/a
36	chr1:215256448-215256498	AG04449	skin:	fetal
37	chr1:215255716-215255766	PrEC	prostate:	n/a
38	chr1:215256635-215256685	HPAEpiC	pulmonary alveolar:	n/a
39	chr1:215256254-215256304	NT2-D1	testis:	n/a
40	chr1:215256745-215256795	SK-N-SH_RA	brain:	n/a
41	chr1:215256870-215256920	IMR90	lung:	fetal
42	chr1:215256262-215256312	GM12892	blood:	n/a
43	chr1:215255572-215255622	PANC-1	pancreas:	n/a
44	chr1:215255572-215255622	RPTEC	kidney:	n/a
45	chr1:215256870-215256920	HEEpiC	esophagus:	n/a
46	chr1:215256451-215256501	MCF10A-Er-Src	breast:	n/a
47	chr1:215256254-215256304	PFSK-1	brain:	n/a
48	chr1:215255572-215255622	HEK293	kidney:	embryo
49	chr1:215256978-215257028	PANC-1	pancreas:	n/a
50	chr1:215256745-215256795	GM06990	blood:	n/a

No data

Variant related genes	Relation type
KCNK2	TF binding region
KCNK2	CpG island

Extended variants
information (count: 71 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:71 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs554847889	chr1:215255683-215255684	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs568261540	chr1:215255726-215255727	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs12742758	chr1:215255731-215255732	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs548553701	chr1:215255766-215255767	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs553744664	chr1:215255768-215255769	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs577188525	chr1:215255782-215255783	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs147225205	chr1:215255845-215255846	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs556502902	chr1:215255869-215255870	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs140485313	chr1:215255872-215255873	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs541916559	chr1:215255946-215255947	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs28545309	chr1:215255977-215255978	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs116037885	chr1:215256035-215256036	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs12743287	chr1:215256056-215256057	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs541727012	chr1:215256075-215256076	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs529378927	chr1:215256169-215256170	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs12747186	chr1:215256180-215256181	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs12747319	chr1:215256199-215256200	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs533655645	chr1:215256244-215256245	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs537215270	chr1:215256287-215256288	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs562497697	chr1:215256318-215256319	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs531483669	chr1:215256440-215256441	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs201482650	chr1:215256538-215256539	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs548262217	chr1:215256542-215256543	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs370946670	chr1:215256544-215256545	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs557555919	chr1:215256545-215256546	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs533944882	chr1:215256568-215256569	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs377170755	chr1:215256611-215256612	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs370361294	chr1:215256626-215256627	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs200437003	chr1:215256635-215256636	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs376084267	chr1:215256638-215256639	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs371586961	chr1:215256644-215256645	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs201512454	chr1:215256646-215256647	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs376060078	chr1:215256653-215256654	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs368385202	chr1:215256673-215256674	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs372387400	chr1:215256685-215256686	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs375480163	chr1:215256706-215256707	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs368043036	chr1:215256710-215256711	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs147376791	chr1:215256721-215256722	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs371595283	chr1:215256727-215256728	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs199698339	chr1:215256758-215256759	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs574383045	chr1:215256780-215256781	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs376185991	chr1:215256781-215256782	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs371383172	chr1:215256810-215256811	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs570938656	chr1:215256831-215256832	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs539971501	chr1:215256846-215256847	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs376231574	chr1:215256855-215256856	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs572329515	chr1:215256873-215256874	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs551109554	chr1:215256875-215256876	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs61818297	chr1:215256888-215256889	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs578217149	chr1:215256920-215256921	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
Multiple myeloma	16461302	CNVD
van der Woude syndrome	22470819	CNVD
van der Woude syndrome	20818247	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21720365	CNVD
small cell lung cancer	20016488	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Medulloblastoma	16783165	CNVD
Basal cell lymphoma	17170743	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Holoprosencephaly	19184110	CNVD
Breast cancer	21069454	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Mental retardation	19951919	CNVD
Non-syndromic sensorineural hearing loss	17873649	CNVD
Acute myeloid leukemia	17268525	CNVD
Lung cancer	16740712	CNVD
Renal cell carcinoma	18765545	CNVD
Basal cell lymphoma	17053054	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:274 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:215254800-215257400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
2	chr1:215254800-215257400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
3	chr1:215254800-215259000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr1:215254800-215260000	Active TSS	Fetal Brain Female	brain
5	chr1:215255000-215255800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
6	chr1:215255000-215256000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr1:215255000-215256000	Enhancers	Pancreas	Pancrea
8	chr1:215255000-215256200	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
9	chr1:215255000-215256800	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
10	chr1:215255000-215257000	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
11	chr1:215255000-215257200	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
12	chr1:215255000-215257200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
13	chr1:215255000-215257400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
14	chr1:215255000-215257400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
15	chr1:215255000-215258400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr1:215255200-215255800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
17	chr1:215255200-215255800	Bivalent Enhancer	Fetal Lung	lung
18	chr1:215255200-215255800	Flanking Active TSS	NHLF	lung
19	chr1:215255200-215256000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
20	chr1:215255200-215256000	Bivalent Enhancer	Fetal Heart	heart
21	chr1:215255200-215256000	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
22	chr1:215255200-215256000	Flanking Active TSS	NH-A	brain
23	chr1:215255200-215256200	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
24	chr1:215255200-215256800	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
25	chr1:215255200-215256800	Active TSS	Brain Anterior Caudate	brain
26	chr1:215255200-215257000	Active TSS	Muscle Satellite Cultured Cells	--
27	chr1:215255200-215257000	Enhancers	Spleen	Spleen
28	chr1:215255200-215257200	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr1:215255200-215257200	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
30	chr1:215255200-215258600	Active TSS	Fetal Brain Male	brain
31	chr1:215255200-215259000	Active TSS	NHDF-Ad	bronchial
32	chr1:215255400-215255800	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
33	chr1:215255400-215255800	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
34	chr1:215255400-215255800	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
35	chr1:215255400-215255800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
36	chr1:215255400-215255800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr1:215255400-215255800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr1:215255400-215255800	Bivalent Enhancer	Adipose Nuclei	Adipose
39	chr1:215255400-215255800	Flanking Active TSS	Brain Angular Gyrus	brain
40	chr1:215255400-215255800	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
41	chr1:215255400-215255800	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
42	chr1:215255400-215255800	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
43	chr1:215255400-215256000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
44	chr1:215255400-215256000	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
45	chr1:215255400-215256000	Flanking Bivalent TSS/Enh	Brain Inferior Temporal Lobe	brain
46	chr1:215255400-215256000	Bivalent Enhancer	Esophagus	oesophagus
47	chr1:215255400-215256000	Flanking Bivalent TSS/Enh	NHEK	skin
48	chr1:215255400-215256200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr1:215255400-215256200	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
50	chr1:215255400-215256600	Bivalent/Poised TSS	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links